发明名称 C2ORF18 AS TARGET GENE FOR CANCER THERAPY AND DIAGNOSIS
摘要 Described herein are objective methods for detecting or diagnosing a predisposition to developing cancer, particularly pancreatic cancer. In one embodiment, the diagnostic method involves the step of determining an expression level of C2orf18 using anti-C2orf18 antibody. The present invention further provides methods of screening for therapeutic agents useful in the treatment of a C2orf18-associated disease, such as a cancer, e.g. pancreatic cancer, methods of inhibiting the cell growth and treating or alleviating their symptom. The invention also features products, such as polynucleotides, polypeptides, and vectors double-stranded molecules, antibodies, vectors and compositions composed thereof.
申请公布号 US2011098339(A1) 申请公布日期 2011.04.28
申请号 US20090921766 申请日期 2009.03.10
申请人 ONCOTHERAPY SCIENCE, INC. 发明人 NAKAMURA YUSUKE;NAKAGAWA HIDEWAKI;NAKATSURU SHUICHI
分类号 A61K31/713;A61P35/00;C07H21/00;C12N15/63;G01N33/68 主分类号 A61K31/713
代理机构 代理人
主权项
地址